Afinitor (Everolimus) Combo For Breast Cancer Approved By FDA
Medical News Today
The FDA has approved Afinitor (everolimus) in combination with Aromasin (exemestane) for the treatment of some postmenopausal females with advanced hormone-receptor positive, HER2-negative breast cancer. The FDA (Food and Drug Administration) says the ...
Novartis' breast cancer drug, Afinitor receives US FDA
FDA Approves mTOR Inhibitor Everolimus for Breast CancerOb.Gyn. News Digital Network
FDA approves Afinitor for Advanced Breast CancerCounsel & Heal
Pharmaceutical Business Review -Philadelphia Inquirer -Reuters India
all 90 news articles »